INTEGRATED BIOPHARMA INC (INBP) Operating margin 2016–2025
INTEGRATED BIOPHARMA INC (INBP) operating margin by fiscal year — reported operating income divided by reported revenue.
3.7%FY2025 · since FY2016: 5.0% → 3.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 3.7% | +3.2 pp |
| FY2024 | 0.5% | +0.3 pp |
| FY2023 | 0.2% | -4.6 pp |
| FY2022 | 4.9% | -4.2 pp |
| FY2021 | 9.1% | +2.9 pp |
| FY2020 | 6.2% | +0.8 pp |
| FY2019 | 5.4% | +1.5 pp |
| FY2018 | 3.9% | -2.9 pp |
| FY2017 | 6.8% | +1.8 pp |
| FY2016 | 5.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice